Form4.ai tracks every SEC insider trade in real time. See every RGNX insider filing with a free account — no card.
See every RGNX insider filing — free account, no card.
Free accountREGENXBIO Inc. (RGNX) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $949K. Most recent filing: Nov. 3, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 3, 2026 SEC filing | Malzahn Craig Chief Technology Officer | Grant / award | — | — |
| Nov 3, 2026 SEC filing | Christmas Patrick J. Chief Strategy & Legal Officer | Grant / award | — | — |
| Nov 3, 2026 SEC filing | PAKOLA STEVE Chief Medical Officer | Grant / award | — | — |
Create a free account to see all 6 RGNX filings from the last 90 days. No card needed.
Create free accountWant RGNX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.